1 / 48

Anemia: A Public Health Problem

Anemia: A Public Health Problem . Aryeh Shander, MD, FCCM, FCCP Dept. of Anesthesiology, Critical Care & Hyperbaric Medicine Englewood Hospital and Medical Center, Englewood, NJ Clinical Professor of Anesthesiology, Medicine & Surgery Mount Sinai School of Medicine, New York, NY.

tyme
Télécharger la présentation

Anemia: A Public Health Problem

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anemia: A Public Health Problem Aryeh Shander, MD, FCCM, FCCP Dept. of Anesthesiology, Critical Care & Hyperbaric Medicine Englewood Hospital and Medical Center, Englewood, NJ Clinical Professor of Anesthesiology, Medicine & Surgery Mount Sinai School of Medicine, New York, NY Recommendations from the SABM Anemia Advisory Board

  2. WHO Definition of Anemia vs. Hb Distribution in General Population Anemia in Men: Hb <13 g/dL Anemia in Women: Hb <12 g/dL Hb Distribution in Women:13.3 g/dL 0.9 g/dL 3000 Hb Distribution in Men:15.2 g/dL0.9 g/dL 2500 2000 Frequency 1500 1000 500 0 10 10.5 11 11.5 12 12.5 13 13.5 14 14.5 15 15.5 16 16.5 17 17.5 18 Hb Level (g/dL) 1. World Health Organization. Geneva, Switzerland; 2001. 2. Dallman PR, et al. In: Iron Nutrition in Health and Disease London, UK: John Libbey& Co; 1996:65-74.

  3. VARIOUS DEFINITIONS OF ANEMIA Men Women 16 14.2 14 14 14 13.2 13.2 13 12.3 12.2 12 12 11.7 11.6 12 10 Hb (g/dL) 8 6 4 2 0 WHO Jandl Williams Wintrobe Rapaport Goyette Beutler E, et al. Blood. 2006;107(5):1747-1750.

  4. Anemia by the numbers (USA) • Prevalence of Anemia: Approx 1 in 77 or 1.29% or 3.5 million (NHLBI and Mayo Clinic) • 7% of children aged 1-2 had anemia in the US 1999-2000 (MMWR, NCHS, CDC) • 12% of women aged 12-49 had anemia in the US 1999-2000 (MMWR, NCHS, CDC) • 174,600 nursing home residents had anemia in the US 1999 (National Nursing Home Survey, NCHS, CDC) • 4,627 people died from anemia each year in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC) • 1.6 people per 100,000 died from anemia each year in the US 2001 (Deaths: Final Data for 2001, NCHS, CDC)

  5. Recent Data On AnemiaIn Specific Populations Prevalence & Significance Prevalence & Significance Recent Data On AnemiaIn Specific Populations

  6. Outpatient Populations • Bager et al (2011): • Anemia in 19% of 429 IBD patients • 20% IDA; 12% ACD; 68% IDA+ACD • <5% had folate or B12 deficiency • Jones et al (2010): • Anemia in 15% of 234 pts attendingdiabetesclinics • 34% Epo deficiency; 40% abnormal hematinics; 26% unexplained • Jorgensen et al (2010): • Anemia in 3.4% of 5,286 individuals 55-74 yrs old • Anemia associated with 2.15 higher risk of non-vertebral fractures in men • Lipinski et al (2009): • Anemia in 9% of 1,799 patients referred for routine exercise testing • Significantly higher mortality (p<0.05) and cardiovascular events (p<0.001) • Zoppini et al (2010): • Anemia in 18.4% of 1,153 type 2 diabetic outpatients • Independently associated with all-cause (HR 2.11) & cardiovascular mortality (HR 2.23)

  7. Outpatient Populations • Kim et al (2011): 7,607 Koreans aged ≥10 yrs

  8. General Non-Surgical (Inpatient) • Nathavitharana et al (2011): • 33.3% in 1,491 non-surgical inpatient admissions • Independently associated with increased: • LOS (p <0.001) • Mortality (p <0.001) • Unplanned hospital readmission (p <0.001) • Shema-Didi et al (2010): • 27.6% in 19,271 patients with normal kidney activity admitted to hospital • Anemia at admission was associated with occurrence of acute kidney injury after controlling for potential confounders (OR 1.5)

  9. Elderly

  10. Elderly • Resnick et al (Clin Nurs Res. 2010): • 9 case control studies - A total of 451 residents from 12 nursing homes • Average age 83.74±8.24 • 79% female • 245 (54%) were anemic • Physical performance was worse in those with anemia, and those with anemia associated with chronic kidney disease had lower self-efficacy and outcome expectations for functional activities than those without anemia

  11. Heart Failure • Aleksova et al (2011): • 13% at baseline and 39% new-onset in 491 patients with idiopathic dilated cardiomyopathy • Anemia at baseline - an independent predictor of outcome of transplant or death (HR 1.85) • New-onset of anemia - an independent predictor of poor outcome (HR 2.85) • Hamaguchi et al (2009): • 57% in 1960 patients hospitalized with worsening HF • Increased risk of all-cause death, cardiac death, and rehospitalization after multivariable adjustment • Peterson et al (2010): • 45% at hospitalization and 35% during follow-up in 2,478 patients discharged with HF • Increased mortality rate If persistent (HR 1.65) or progressively declining Hb (HR 1.54)

  12. Heart Failure • Saraiva et al (2011): • 43.2% in 391 patients admitted to an advanced HF care unit • Independent predictor of mortality at 1 year (p=0.035) • Tarantini et al (2011): • 31% in 2,318 patients with acute HF • In-hospital mortality was 12% and 5.3% in anemic vs. non-anemic patients (p<0.0001); an independent predictor of in-hospital mortality • von Haehling et al (2010): • 29% in 627 patients admitted with acute HF • Patients with moderate-severe anemia had increased 12-month mortality (HR 1.5, p=0.01) after adjusting for other factors

  13. Heart Failure • Incidence of anemia in HF

  14. Ischemic Heart Diseases

  15. Ischemic Heart Diseases

  16. Respiratory Diseases

  17. Cerebrovascular Accidents • Sico et al (2011): • 6.4% in 1,306 ischemic stroke patients at admission • Independently associated with worse outcome (OR 4.17) • Tanne et al (2010): • 19% in 859 patients with acute stroke • After adjustment for baseline characteristics, anemia at admission was associated with: • Increased risk of all-cause death at 1-month (OR 1.9) and 1-year (1.72) • Increased disability (OR 2.09) • Increased nursing facility care (OR 1.83)

  18. Critically Ill • Cardenas-Turanzas et al (2010): • Anemia prevalence was 68% and anemia incidence was 46.6% in 4,705 cancer patients admitted to ICU • Thomas et al (2010): • Anemia was present in 98% of 100 consecutive adults admitted to a general ICU

  19. Oncology/Oncosurgery

  20. Reduced Treatment Success Decreased QoL Decreased Survival Oncology/Oncosurgery • Clinical consequences of anemia in cancer patients • Less loco-regional control after radiation therapy • Increased relapse rate

  21. Ob/Gyn

  22. Cardiac Surgery

  23. Orthopedic Procedures

  24. Orthopedic Procedures • Spahn – A systematic review (Anesthesiology 2010): • Prevalence of anemia • Hip - 24±9% • Knee - 44±9% • Transfusion rate • Hip - 45±25% • Knee - 44±15% • Anemic patients had higher rates of: • Infection • Poor physical recovery • HLOS • Mortality (13% vs. 6%)

  25. No HF, No CKD, No Anemia 1 Anemia Only 1.9 CKD Only 2.05 HF Only 2.86 CKD, Anemia 3.37 HF, Anemia 3.78 HF, CKD 4.86 HF, CKD, Anemia 6.07 0 1 2 3 4 5 6 7 Relative Risk of 2-Year Mortality Anemia: A Potent Multiplier of Mortality N = 1.1 million (5% Medicare sample, 1996-1997) Herzog CA, et al. Presented at: 6th Annual Scientific Meeting of the Heart Failure Society of America; September 22-25, 2002; Boca Raton, Florida. Abstract 226.

  26. 3.5% Preoperative anemia 3.0% 2.5% 2.0% Mortality 1.5% 1.0% No anemia 0.5% 0.0% 0 30 60 90 Postoperative Day Risks of Preop Anemia in Non-Cardiac Surgeries • Beattie SW et al (Anesthesiology 2009): • Retrospective Data collection (n= 7,759) 2003 – 2006 • Preoperative anemia (39.5% for men and 39.9% for women) – 5 fold increase in odds of post op mortality • After adjustment for major confounders, anemia was still associated with increased mortality (odds ratio, 2.36; 95% confidence interval, 1.57-3.41) • Anemia is a common condition in surgical patients and is independently associated with increased mortality.

  27. Preop Anemia & Postop Outcomes in Non-Cardiac Surgeries • Musallam KM et al (Lancet 2011) – A cohort study • 2008 - ACS NSQIP (211 Hospitals) • N= 227,425 • Preop anemia: 30% • Preop anemia independently associated with increased risk of 30-day morbidity and mortality

  28. Preop Anemia & Postop Outcomes in Non-Cardiac Surgeries • 30-day mortality, by anemia and risk factor status Musallam KM et al. Lancet 2011

  29. Blood Loss from Phlebotomy Blood Drawn (mL/day) Smoller BR, et al. N Engl J Med. 1986;314:1233-1235.

  30. Diagnostic Blood Loss From Phlebotomy and Hospital-Acquired Anemia (HAA) During Acute Myocardial Infarction • N= 17 676 patients with AMI from 57 US hospitals - AMI database ( Jan 2000- Dec 2008) • Moderate to severe HAA developed in 3551 patients (20%). • The mean (SD) phlebotomy volume was higher : • HAA (173.8 [139.3] mL) vs those without HAA (83.5 [52.0 mL]; P < .001) • There was significant variation in the mean diagnostic blood loss across hospitals • For every 50 mL of blood drawn, the risk of moderate to severe HAA increased by 18% (relative risk [RR], 1.18; 95% confidence interval [CI], 1.13-1.22) • Blood loss from \phlebotomy is independently associated with the development of HAA. Salisbury, A. C. et al. Arch Intern Med 2011;171:1646-1653

  31. Variation in mean diagnostic blood loss (DBL) across the 57 hospitals Salisbury, A. C. et al. Arch Intern Med 2011;171:1646-1653

  32. Anemia, Comorbidities, Txn & Outcomes Shander A et al. Br J Anaesth 2011

  33. Summary of Data • Anemia – A public health problem • Prevalence varies from population to population and region to region • The prevalence is often high (higher than expected) • An independent predictor of worse outcomes • Mortality • Morbidity • QoL • Likely to be under-screened/under-diagnosed • Responds well to treatment

  34. Anemia Advisory Board • Why SABM got invovled? • Plan: Convene a one-day Advisory Panel of anemia and PBM experts • Sponsor: AMAG Pharmaceuticals • Proposed faculty • AryehShander, MD, FCCM, FCCP - Chair • Lawrence T. Goodnough, MD, co-Chair • Jeffrey Carson, MD • Michael Auerbach, MD • William Ershler, MD • John Glaspy, MD • Indu Lew, PharmD • Mary Ghiglione, RN, BSN, MSN, MHA • MazyarJavidroozi, MD, PhD (Researcher/Writer)

  35. Anemia Advisory Board May 31, 2012 - Santa Monica, CA

  36. Key Conclusions • Anemia definition: • Abide by WHO definitions • Prevalence of anemia high in hospitalized populations • Anemia is associated with worse outcome • Survival, morbidity, hospital LOS • Anemia is a modifiable risk of (for) transfusion • Hospital-acquired anemia (new or exacerbated) is often: • Overlooked, under-attended, under-appreciated • Likely to further worsen outcomes

  37. Key Questions NATA Guidelines Goodnough LT et al. Br J Anaesth. 2011 • What is recommended to detect anemia in patients? • What diagnostic tests are best suited for evaluation of anemia? • What to do in special populations?

  38. Key Recommendations • In general: • NATA guidelines  Importance of pre-admission screening/diagnosis • Diagnostic tests: • CBC  Anemia Yes/No • TSAT (cut-off 20%)  ID Yes/No • Once IDA diagnosis is established  Iron • Oral – Barriers: • 2-4 mg absorbed per day • Adherence – (Compliance) • IV Iron Dextran - Barriers: • Test dose – crash cart • Reimbursement • Infusion clinics • If TSAT>20% • Retic Hb concentration • % hypochromic retics •  Iron • GI evaluation

  39. Key Recommendations • Surgical patients • Elective: NATA guidelines in general • Screening • CBC • TSAT • Treatment • Iron • Cardiac/CABG: • Also follow STS guidelines

  40. Key Recommendations • Hospitalized Patients • HAA • Screen on admission - • Iron sat at discharge; follow same algorithm • Utilization review/oversight of unnecessary/redundant tests • Small volume/peds tubes • Minimize standing orders for diagnostic testing

  41. Key Recommendations • Elderly – high prevalence with associated adverse outcomes • Detection – annual CBC • Need for endorsement by CMS? • Evaluation - same algorithm • Iron therapy if TSAT<20%

  42. Key Recommendations • Women • Pre-natal care (ACOG guidelines lacking?) • Intolerance to prenatal vitamins/oral iron • Opportunity for other supplemental therapies • Post-Partum • Discharge Iron Rx • TSAT<20%: IV Iron • Need for clinical trials • Dysfunctional uterine bleeding • IV Iron Rx

  43. Key Recommendations • Oncology patients undergoing cancer treatment • Detection: CBC • Evaluation: TSAT screening for every patient • Treatment – algorithm • ESA patients • Give IV iron independent of baseline TSAT for optimal dose response • European published guidelines recommend treatment based on Sx • Early intervention when Hb<11.5 vs. Hb<10

  44. Key Recommendations • Congestive heart failure: • Detection – CBC (Esp NYHA class II and III) • Evaluation TSAT <20% vs. >20% • Management : algorithm • Coronary syndrome: • ~30% have hgb< 11; ~20% have hgb<10 • Detection – CBC • Evaluation - TSAT • Management – algorithm

  45. Key Recommendations • Cerebrovascular accidents  Same approach • Respiratory diseases  Same approach • Critically ill: • Oxidative stress models • Same approach • Exception: • Not for overtly septic patients. • For patients with uncontrollable infections – watchful waiting

  46. Need for More Research • Impact on improved clinical outcomes • Management in geriatrics with anemia • Adverse events and role of premedication • Importance of anemia

  47. THANK YOU

More Related